FDA News
🇺🇸 FDA Page 25FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 289–300 of 391 articles
U.S. Pressure on Germany's Drug Prices: Implications for Pharma
Makary Resigns as FDA Commissioner: Implications for Drug Approvals
US Cancer Clinics Rush for Revolution Medicines' New Pancreatic Cancer Drug
CDER Chief Høeg Fired: Implications for Pharma Industry
Holland & Knight Health Dose: Oncology Updates from May 12, 2026
FDA Roundup: Oncology Drug Approvals in 2026
FDA Grants Dual Approval for T-DXd in HER2+ Early Breast Cancer
Four FDA Actions Reshaping Drug Development in 2026
FDA Policy Tracker 2026: Psychedelics Regulatory Updates
FDA Blocks Melanoma Drug Amid Confusion Under Makary Leadership
Novel Drug Approvals for 2026: Insights from the FDA
FDA Approves Eli Lilly's Zepbound for Obstructive Sleep Apnea